NUT midline carcinoma: Report of 2 cases suggestive of pulmonary origin

American Journal of Surgical Pathology

Volumn 36, Issue 3, 2012, Pages 381-388

  Tanaka, Mio ^a   Kato, Keisuke ^a,d   Gomi, Kiyoshi ^a   Yoshida, Mariko ^a   Niwa, Tetsu ^a   Aida, Noriko ^a   Kigasawa, Hisato ^b   Ohama, Yokatsu ^c   Tanaka, Yukichi ^a  

^a KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^b Division of Surgical Oncology   (Japan)

^c Division of Surgery   (Japan)

^d Ibaraki Children's Hospital   (Japan)

Author keywords

in situ lesion; lung; NUT midline carcinoma

Indexed keywords

BRD4 NUT FUSION ONCOGENE PROTEIN, HUMAN; BRD4-NUT FUSION ONCOGENE PROTEIN, HUMAN; KERATIN; NUCLEAR PROTEIN; NUT PROTEIN, HUMAN; ONCOPROTEIN; THYROID NUCLEAR FACTOR 1; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ARTICLE; BIOPSY; CASE REPORT; CELL DIFFERENTIATION; CHEMISTRY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FATALITY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; METASTASIS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD TUMOR; SQUAMOUS CELL CARCINOMA; TIME; TREATMENT OUTCOME;

ADOLESCENT; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CHILD; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LUNG NEOPLASMS; MALE; NUCLEAR PROTEINS; ONCOGENE PROTEINS; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84862796545     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31824230a8     Document Type: Article

References (23)

1. Cohen MC, Kaschula RO. Primary pulmonary tumors in childhood: a review of 31 years' experience and the literature. Pediatr Pulmonol. 1992;14:222-232.
2. Dang TP, Gazdar AF, Virmani AK, et al. Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst. 2000;92:1355-1357.
3. den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, et al. NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol. 2009;33:1253-1258.
4. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8:494-501.
5. Di Loreto C, Di Lauro V, Puglisi F, et al. Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol. 1997;50:30-32.
6. French CA. Demystified molecular pathology of NUT midline carcinomas. J Clin Pathol. 2010;63:492-496.
7. French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004;22:4135-4139.
8. French CA, Miyoshi I, Kubonishi I, et al. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003;63:304-307.
9. Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984-991.
10. Hancock BJ, Di Lorenzo M, Youssef S, et al. Childhood primary pulmonary neoplasms. J Pediatr Surg. 1993;28:1133-1136.
11. Haruki N, Kawaguchi KS, Eichenberger S, et al. Cloned fusion product from a rare t (15;19) (q13.2;p13.1) inhibit S phase in vitro. J Med Genet. 2005;42:558-564.
12. Ishiwa N, Nakatani Y, Inayama Y, et al. Immunohistochemical study of thyroid transcription factor-1 expression in lung cancers. Jpn J Lung Cancer. 2001;41:45-49.
13. Kees UR, Mulcahy MT, Willoughby ML. Intrathoracic carcinoma in an 11-year-old girl showing a translocation t (15;19). Am J Pediatr Hematol Oncol. 1991;13:459-464.
14. Kubonishi I, Takehara N, Iwata J, et al. Novel t (15;19) (q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res. 1991;51:3327-3328.
15. Lal DR, Clark I, Shalkow J, et al. Primary epithelial lung malignancies in the pediatric population. Pediatr Blood Cancer. 2005;45:683-686.
16. Mertens F, Wiebe T, Adlercreutz C, et al. Successful treatment of a child with t (15;19)-positive tumor. Pediatr Blood Cancer. 2007;49:1015-1017.
17. Morotti RA, Gutierrez MC, Askin F, et al. Expression of thyroid transcription factor-1 in congenital cystic adenomatoid malformation of the lung. Pediatr Dev Pathol. 2000;3:455-461.
18. Nagahara N, Nishino T. Role of amino acid residues in the active site of rat liver mercaptopyruvate sulfurtransferase. CDNA cloning, overexpression, and site-directed mutagenesis. J Biol Chem. 1996;271:27395-27401.
19. Nagakawa H, Airoshima K, Takiguchi Y, et al. Basaloid squamouscell carcinoma of the lung in a young woman. Int J Clin Oncol. 2006;11:66-68.
20. Pelosi G, Fraggetta F, Pasini F, et al. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol. 2001;25:363-372.
21. Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32:828-834.
22. Wang BY, Gil J, Kaufman D, et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol. 2002;33:921-926.
23. Ziai J, French CA, Zambrano E. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland. Head Neck Pathol. 2010;4:163-168.